"Obesity Drug Discontinuation Dilemma: The Struggle to Maintain Weight Loss Post-Medication"

Individuals using Ozempic and Wegovy, drugs initially designed for Type 2 diabetes, for weight loss are experiencing significant weight regain after discontinuing the medication. Patients like Artemis Bayandor have reported gaining more weight than they lost, highlighting the drugs' temporary effect on appetite and fullness. Health experts emphasize that these medications should be taken long-term, similar to treatments for other chronic conditions, to maintain weight loss. However, the high cost and severe side effects, including gastroparesis and unusual dreams, have led some to stop the treatment, resulting in weight gain and other issues like "Ozempic finger" and "Ozempic burp."